Vivek Subbiah: Why Traditional RCT-focused Reviews May Miss the Mark in Precision Medicine Era

Vivek Subbiah, Future of Cancer Treatment

PRODIGE-13 Trial Results: Do We Really Need 5 Years of CT and CEA Follow-Up in CRC?

PRODIGE-13 Trial Results: Do We Really Need 5 Years of CT and CEA Follow-Up in CRC?

Florian Scotté: Fast-Track Safety Evaluation in Anticancer Drug Development

Florian Scotté

Michelle Mitchell Welcomes Pete Markey as CRUK’s New Executive Director

Michelle Mitchell

Arndt Vogel: Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Arndt Vogel

Oncology News, Insights, Stories by OncoDaily

100 Influential Women in Oncology
Positive

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

Greenwich LifeSciences’ GLSI-100 Receives FDA Fast Track Designation for Preventing Breast Cancer Recurrence
FDA Approvals

Greenwich LifeSciences’ GLSI-100 Receives FDA Fast Track Designation for Preventing Breast Cancer Recurrence

Giuseppe Curigliano
Voices

Giuseppe Curigliano: The Path to A Successful Career

Sakditad Saowapa: Clifford Hudis Suggested Top 3 Influential Books on Leadership and Success

W. Michael Korn: Biocartis Received FDA Approval for the Idylla CDx MSI Test

The 2025 China-Hungary Anti-Cancer Summit: Bridging Expertise in Cancer Care

The Servier Golden Ticket is Back in 2025!

Eduardo Bruera: Palliative Care Education and Research at US Cancer Centers

Richard Sullivan: Global Health Funding Is Vaporising, Cancer Research Under Threat

Global Voices in Renal Oncology (VIRO) 2025 Comes to a Close: A Global Success Story

awards
awards
awards
awards
awards
awards

Voices
Mathukumilli Sribharat

Ravindran Kanesvaran: Honored to Host Indian MP Mathukumilli Sribharat at NCCS

Wafik El-Deiry: Great to See Fellow Cancer Center Directors at the 2025 Rally for Medical Research

Maite Bourlon: Honored to Join Katherine Van Loon in Advancing JCO Global Oncology

Fabio Ynoe de Moraes: It’s Time to Transform Lung Cancer Care - A Global Policy Imperative

Strong Voter Backing for Increased Cancer and Medical Research Funding - AACR

Shaheenah Dawood: Can Daily Low-Dose Aspirin Lower Recurrence in PIK3CA-Mutant Colorectal Cancer?

Liang Cheng: The 2nd Annual Advancing Precision Medicine Conference

Celebrities and Cancer

OncoCalendar

ESMO Guidelines 2025: Real World Cases - Webinar Series on Melanoma

European Society For Medical Oncology (ESMO)

24 Sep
ESMO Guidelines 2025

The ESMO Advanced Course on ADC Development, Therapeutic Applications, and Research in Thoracic Cancers 2025

European Society For Medical Oncology (ESMO)

24 Sep
esmo

The ESO Refresher Course on Breast Cancer

European School of Oncology

21 Nov
ESO

CCI4EU 3rd Capacity Building Conference on Effective Patient Pathways

European School of Oncology

15 Oct
CCI4EU Conference

10th ESO SIOPE Masterclass in Paediatric Oncology

European School of Oncology

01 Oct
ESO SIOPE

Immune-oncology
Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

10 Must-Read Posts in Immuno-Oncology This Week

LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC

Top Immunotherapy Trials in Head and Neck and Endocrine Cancers to Watch at ESMO 2025

10 Must-Read Posts in Immuno-Oncology This Week

BOT/BAL Advancements, BATTMAN Trial, FDA Approval Challenges and Key Highlights from Agenus Stakeholder Briefing

ROWAN Study of TheraSphere with Durvalumab and Tremelimumab in HCC Completed Enrollment

OncoGrants
Molecular Imaging of Inflammation in Cancer

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

research funding

Specialized Programs of Research Excellence in Human Cancers (P50 Clinical Trial Required)

assay

Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

Innovative Research in Cancer Nanotechnology (R01 Clinical Trial Not Allowed)

Innovative Research in Cancer Nanotechnology (R01 Clinical Trial Not Allowed)

NCI Exploratory/Developmental Research Grant

NCI Exploratory/Developmental Research Grant

cancer

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care
Oncologist Near Me

Oncologist Near Me - Guillermo Chantada: A Leading Expert in Pediatric Oncology

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologist
Aparna Parikh

Aparna Parikh

Boston, USA
Rachna Shroff

Rachna Shroff

Tucson, USA
Gregory Kalemkerian

Gregory Kalemkerian

Ann Arbor, USA
Hagop-Kantarjian

Hagop Kantarjian

Houston, USA
Sarkis Meterissian

Sarkis Meterissian

Montreal, Canada
Florian Lordick

Florian Lordick

Leipzig, Germany
LIdia Schapira

Lidia Schapira

Stanford, USA
Matti Aapro

Matti Aapro

Genolier, Switzerland
Rob Pieters

Rob Pieters

Utrecht, Netherlands
Giuseppe Curigliano

Giuseppe Curigliano

Milan, Italy
Yelena Janjigian

Yelena Janjigian

New York, USA

Oncology Drugs
Zongertinib (Hernexeos)

Zongertinib (Hernexeos) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Dordaviprone (Modeyso) 2025: What patients need to know?

The FDA Has Granted Accelerated Approval to Zongertinib - The Babak Lab

Dordaviprone (Modeyso) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and more

Zanidatamab (Ziihera): Patient Guide for 2025

Zanidatamab (Ziihera) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More

OncoDaily Magazine

awards
awards
awards
awards
awards
awards

New Paper Alert
CABATEN Trial

New Paper Alert: CABATEN Trial Results- Cabozantinib and Atezolizumab Show Durable Responses in Rare Endocrine Cancers

A Systematic Review and Meta-Analysis of Cancer in Inborn Errors of Immunity

A Systematic Review and Meta-Analysis of Cancer in Inborn Errors of Immunity

Nationwide Real-World Evidence of Immunotherapy in Armenia

Nationwide Real-World Evidence of Immunotherapy in Armenia

Amivantamab–Lazertinib Improves Survival Over Osimertinib in EGFR-Mutated NSCLC

Amivantamab–Lazertinib Improves Survival Over Osimertinib in EGFR-Mutated NSCLC

Treatment Abandonment

Childhood Cancer in Pakistan: Factors Driving Treatment Abandonment at a Tertiary Center

Melanoma

Evolution of the treatment of metastatic cutaneous melanoma over the past 5 decades

OncoDaily Medical Journal

Precision Oncology

10.69690/ODMJ-019-0829-4588

Harnessing Real-World Evidence to Support Precision Oncology
Opinion

Pediatric Oncology

10.69690/ODMJ-001-0829-4568

Identifying the Factors Contributing to Treatment Abandonment in Childhood Cancers at a Tertiary Care Hospital in Pakistan
Original Research

Global Oncology

10.69690/ODMJ-001-0811-4701

The Role of National and Regional Cancer Registries in Shaping Cancer Care Policies
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0809-4599

Survival Outcomes of Wilms' Tumor in Pediatric Patients Treated at KFMC: A Retrospective Study of 15 years from 2007-2022
Original Research

GI Oncology

10.69690/ODMJ-018-0425-4320

Colorectal Cancer in Latin America: Quick Comment
Commentaries

GI Oncology

10.69690/ODMJ-002-0701-4309

Current Perspective of Gastro-intestinal Cancer in Guatemala
Review/Meta-Analysis

Pediatric Oncology

10.69690/ODMJ-003-0520-4233

In the Crossfire: A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group
Editorial

Pediatric Oncology

10.69690/ODMJ-018-0425-4062

CD19+ CAR-T Therapy for Relapsed or Refractory B-ALL and Burkitt Lymphoma in Children and Young Adults in the Republic of Belarus
Abstracts